7Baggers

AtriCure Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -18.563.5425.6447.7469.8491.94114.04136.14Milllion

AtriCure Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 
                                                                                   
  revenue136,139,000 123,620,000 124,277,000 115,910,000 116,269,000 108,851,000 106,543,000 98,290,000 100,918,000 93,494,000 88,028,000 83,246,000 84,529,000 74,576,000 73,218,000 70,460,000 71,376,000 59,275,000 57,725,000 54,757,000 40,824,000 53,225,000 61,321,000 56,614,000 58,906,000 53,966,000 52,893,000 49,941,000 51,802,000 46,994,000 46,062,000 42,150,000 45,231,000 41,273,000 41,157,000 38,340,000 39,672,000 35,940,000 35,863,000 31,423,000 32,583,000 29,886,000 29,415,000 26,678,000 26,514,000 24,847,000 21,884,000 20,146,000 20,429,000 19,430,000 18,364,000 16,139,000 18,268,000 17,476,302 16,763,697 15,222,068 16,779,563 15,637,081 16,388,963 14,473,113 14,192,312                     
  yoy17.09% 13.57% 16.64% 17.93% 15.21% 16.43% 21.03% 18.07% 19.39% 25.37% 20.23% 18.15% 18.43% 25.81% 26.84% 28.68% 74.84% 11.37% -5.86% -3.28% -30.70% -1.37% 15.93% 13.36% 13.71% 14.84% 14.83% 18.48% 14.53% 13.86% 11.92% 9.94% 14.01% 14.84% 14.76% 22.01% 21.76% 20.26% 21.92% 17.79% 22.89% 20.28% 34.41% 32.42% 29.79% 27.88% 19.17% 24.83% 11.83% 11.18% 9.55% 6.02% 8.87% 11.76% 2.29% 5.17% 18.23%                         
  qoq10.13% -0.53% 7.22% -0.31% 6.81% 2.17% 8.40% -2.60% 7.94% 6.21% 5.74% -1.52% 13.35% 1.85% 3.91% -1.28% 20.42% 2.69% 5.42% 34.13% -23.30% -13.20% 8.31% -3.89% 9.15% 2.03% 5.91% -3.59% 10.23% 2.02% 9.28% -6.81% 9.59% 0.28% 7.35% -3.36% 10.38% 0.21% 14.13% -3.56% 9.02% 1.60% 10.26% 0.62% 6.71% 13.54% 8.63% -1.39% 5.14% 5.80% 13.79% -11.65% 4.53% 4.25% 10.13% -9.28% 7.31% -4.59% 13.24% 1.98%                      
  cost of revenue34,657,000 30,992,000 31,658,000 29,117,000 29,425,000 27,583,000 26,728,000 24,421,000 23,841,000 23,885,000 22,915,000 21,533,000 21,010,000 18,981,000 18,202,000 18,234,000 17,298,000 14,735,000 15,288,000 14,423,000 13,170,000 14,341,000 16,547,000 14,817,000 15,013,000 14,095,000 14,303,000 13,993,000 13,723,000 12,491,000 13,379,000 11,232,000 12,677,000 11,265,000 12,260,000 10,868,000 10,854,000 10,026,000 10,318,000 8,945,000 9,466,000 8,151,000 8,995,000 7,786,000 7,733,000 7,190,000 6,215,000 5,461,000 5,306,000 5,344,000 5,362,000 4,590,000 5,557,000 4,724,500 5,022,972 4,136,651 4,502,085 3,744,277 4,082,993 3,299,152 2,963,673                     
  gross profit101,482,000 92,628,000 92,619,000 86,793,000 86,844,000 81,268,000 79,815,000 73,869,000 77,077,000 69,609,000 65,113,000 61,713,000 63,519,000 55,595,000 55,016,000 52,226,000 54,078,000 44,540,000 42,437,000 40,334,000 27,654,000 38,884,000 44,774,000 41,797,000 43,893,000 39,871,000 38,590,000 35,948,000 38,079,000 34,503,000 32,683,000 30,918,000 32,554,000 30,008,000 28,897,000 27,472,000 28,818,000 25,914,000 25,545,000 22,478,000 23,117,000 21,735,000 20,420,000 18,892,000 18,781,000 17,657,000 15,669,000 14,685,000 15,123,000 14,086,000 13,002,000 11,549,000 12,711,000 12,751,802 11,740,725 11,085,417 12,277,478 11,892,804 12,305,970 11,173,961 11,228,639 10,679,164 10,380,188 10,003,246 10,670,134 10,729,245 8,963,685 11,405,963 11,363,606 10,299,265 10,532,905 9,294,041 9,805,067 8,540,275 8,244,094 7,472,099 7,863,621 7,037,067 6,415,479 5,154,290 5,752,291 
  yoy16.86% 13.98% 16.04% 17.50% 12.67% 16.75% 22.58% 19.70% 21.34% 25.21% 18.35% 18.17% 17.46% 24.82% 29.64% 29.48% 95.55% 14.55% -5.22% -3.50% -37.00% -2.48% 16.02% 16.27% 15.27% 15.56% 18.07% 16.27% 16.97% 14.98% 13.10% 12.54% 12.96% 15.80% 13.12% 22.22% 24.66% 19.23% 25.10% 18.98% 23.09% 23.10% 30.32% 28.65% 24.19% 25.35% 20.51% 27.15% 18.98% 10.46% 10.74% 4.18% 3.53% 7.22% -4.59% -0.79% 9.34% 11.36% 18.55% 11.70% 5.23% -0.47% 15.80% -12.30% -6.10% 4.17% -14.90% 22.72% 15.90% 20.60% 27.76% 24.38% 24.69% 21.36% 28.50% 44.97% 36.70%     
  qoq9.56% 0.01% 6.71% -0.06% 6.86% 1.82% 8.05% -4.16% 10.73% 6.90% 5.51% -2.84% 14.25% 1.05% 5.34% -3.42% 21.41% 4.96% 5.21% 45.85% -28.88% -13.15% 7.12% -4.78% 10.09% 3.32% 7.35% -5.60% 10.36% 5.57% 5.71% -5.03% 8.48% 3.84% 5.19% -4.67% 11.21% 1.44% 13.64% -2.76% 6.36% 6.44% 8.09% 0.59% 6.37% 12.69% 6.70% -2.90% 7.36% 8.34% 12.58% -9.14% -0.32% 8.61% 5.91% -9.71% 3.23% -3.36% 10.13% -0.49% 5.15% 2.88% 3.77% -6.25% -0.55% 19.70% -21.41% 0.37% 10.33% -2.22% 13.33% -5.21% 14.81% 3.59% 10.33% -4.98% 11.75% 9.69% 24.47% -10.40%  
  gross margin %74.54% 74.93% 74.53% 74.88% 74.69% 74.66% 74.91% 75.15% 76.38% 74.45% 73.97% 74.13% 75.14% 74.55% 75.14% 74.12% 75.76% 75.14% 73.52% 73.66% 67.74% 73.06% 73.02% 73.83% 74.51% 73.88% 72.96% 71.98% 73.51% 73.42% 70.95% 73.35% 71.97% 72.71% 70.21% 71.65% 72.64% 72.10% 71.23% 71.53% 70.95% 72.73% 69.42% 70.81% 70.83% 71.06% 71.60% 72.89% 74.03% 72.50% 70.80% 71.56% 69.58% 72.97% 70.04% 72.82% 73.17% 76.06% 75.09% 77.20% 79.12%                     
  operating expenses:                                                                                 
  research and development expenses29,284,000 22,528,000 34,957,000 20,960,000 20,416,000 19,845,000 20,796,000 20,354,000 17,438,000 15,327,000 13,748,000 15,169,000 14,791,000 13,629,000 13,808,000 11,284,000 12,197,000 11,217,000 10,871,000 10,576,000 10,036,000 11,587,000 13,096,000 10,154,000 9,804,000 8,176,000 8,455,000 8,556,000 8,655,000 9,057,000 7,721,000 7,966,000 8,907,000 9,550,000 9,866,000 8,271,000 9,124,000 8,563,000 7,767,000 6,504,000 5,862,000 5,609,000 4,997,000 5,033,000 4,569,000 4,001,000 3,648,000 3,237,000 3,049,000 3,506,000 2,967,000 2,905,000 2,885,000 3,388,925 2,964,424 3,069,174 2,878,876 2,944,347 3,513,406 2,937,043 2,422,443 2,657,928 2,778,951 2,580,766 3,138,339 2,916,833 2,573,202 3,008,619 2,593,694 2,433,154 2,532,379 2,397,837 2,927,984 3,129,278 3,204,667 3,172,286 2,928,171 2,910,493 2,788,229 2,612,977 1,970,558 
  selling, general and administrative expenses78,390,000 76,054,000 72,185,000 73,238,000 73,596,000 72,340,000 67,687,000 61,604,000 63,783,000 60,064,000 55,501,000 57,267,000 62,388,000 56,116,000 53,710,000 49,873,000 56,958,000 49,208,000 49,069,000 33,749,000 24,903,000 42,751,000 47,004,000 40,280,000 37,928,000 37,015,000 32,742,000 33,440,000 28,466,000 34,876,000 27,097,000 29,799,000 30,002,000 30,100,000 26,726,000 25,487,000 27,432,000 26,770,000 28,408,000 22,101,000 22,074,000 21,270,000 20,202,000 14,662,000 17,065,000 21,581,000 16,859,000 14,062,000 13,713,000 12,380,000 11,887,000 11,173,000 11,146,000 10,858,863 10,470,922 9,206,794 10,169,771 10,022,652 9,030,330 9,067,807 9,239,056 9,711,522 9,526,734 8,087,896 8,565,233 8,932,143 9,848,900 10,215,477 10,595,334 11,762,426 9,627,487 9,805,004 10,036,836 10,283,187 9,494,000 7,691,260 8,488,970 7,496,098 7,923,639 6,308,516 5,143,086 
  total operating expenses107,674,000 98,582,000 107,142,000 94,198,000 94,012,000 92,185,000 88,483,000 81,958,000 81,221,000 75,391,000 69,249,000 72,436,000 77,179,000 69,745,000   69,155,000 60,425,000 59,940,000 44,325,000 34,939,000 54,338,000 60,100,000 50,434,000 47,732,000 45,191,000 41,197,000 41,996,000 37,121,000 43,933,000 34,818,000 37,765,000 38,909,000 39,650,000 36,592,000 33,758,000 36,556,000 35,333,000 36,175,000 28,605,000 27,936,000 26,879,000 25,199,000 19,695,000 21,634,000 25,582,000 20,507,000 17,299,000 16,762,000 15,886,000 14,854,000 14,078,000 14,031,000 14,247,788 13,435,346 12,275,968 13,048,647 12,966,999 12,543,736 12,004,850 11,661,499 12,369,450 12,494,467 14,435,285 11,703,572 18,661,365 12,422,102 13,224,096 13,189,028 14,195,580 12,159,866 12,202,841 12,964,820 13,412,465 12,698,667 10,863,546 11,417,141 10,406,591 10,711,868 8,921,493  
  income from operations-6,192,000 -5,954,000 -14,523,000 -7,405,000 -7,168,000 -10,917,000 -8,668,000 -8,089,000 -4,144,000 -5,782,000 -4,136,000 -10,723,000 -13,660,000 -14,150,000 -12,502,000 98,669,000 -15,077,000 -15,885,000 -17,503,000 -3,991,000 -7,285,000 -15,454,000 -15,326,000 -8,637,000 -3,839,000 -5,320,000 -2,607,000 -6,048,000 958,000 -9,430,000 -2,135,000 -6,847,000 -6,355,000 -9,642,000 -7,695,000 -6,286,000 -7,738,000 -9,419,000 -10,630,000 -6,127,000 -4,819,000 -5,144,000 -4,779,000 -803,000 -2,853,000 -7,925,000 -4,838,000 -2,614,000 -1,639,000 -1,800,000 -1,852,000 -2,529,000 -1,320,000 -1,495,986 -1,694,621 -1,190,551 -771,169 -1,074,195 -237,766 -830,889 -432,860 -1,690,286 -2,114,279 -4,432,039 -1,033,438 -7,932,120 -3,458,417 -1,818,133 -1,825,422 -3,896,315 -1,626,961 -2,908,800 -3,159,753 -4,872,190 -4,454,573 -3,391,447 -3,553,520 -3,369,524 -4,296,389 -3,767,203 -1,361,353 
  yoy-13.62% -45.46% 67.55% -8.46% 72.97% 88.81% 109.57% -24.56% -69.66% -59.14% -66.92% -110.87% -9.40% -10.92% -28.57% -2572.29% 106.96% 2.79% 14.20% -53.79% 89.76% 190.49% 487.88% 42.81% -500.73% -43.58% 22.11% -11.67% -115.07% -2.20% -72.25% 8.92% -17.87% 2.37% -27.61% 2.60% 60.57% 83.11% 122.43% 663.01% 68.91% -35.09% -1.22% -69.28% 74.07% 340.28% 161.23% 3.36% 24.17% 20.32% 9.29% 112.42% 71.17% 39.27% 612.73% 43.29% 78.16% -36.45% -88.75% -81.25% -58.11% -78.69% -38.87% 143.77% -43.39% 103.58% 112.57% -37.50% -42.23% -20.03% -63.48% -14.23% -11.08% 44.60% 3.68% -9.97% 161.03%     
  qoq4.00% -59.00% 96.12% 3.31% -34.34% 25.95% 7.16% 95.20% -28.33% 39.80% -61.43% -21.50% -3.46% 13.18% -112.67% -754.43% -5.09% -9.24% 338.56% -45.22% -52.86% 0.84% 77.45% 124.98% -27.84% 104.07% -56.89% -731.32% -110.16% 341.69% -68.82% 7.74% -34.09% 25.30% 22.41% -18.76% -17.85% -11.39% 73.49% 27.14% -6.32% 7.64% 495.14% -71.85% -64.00% 63.81% 85.08% 59.49% -8.94% -2.81% -26.77% 91.59% -11.76% -11.72% 42.34% 54.38% -28.21% 351.79% -71.38% 91.95% -74.39% -20.05% -52.30% 328.86% -86.97% 129.36% 90.22% -0.40% -53.15% 139.48% -44.07% -7.94% -35.15% 9.38% 31.35% -4.56% 5.46% -21.57% 14.05% 176.72%  
  operating margin %-4.55% -4.82% -11.69% -6.39% -6.17% -10.03% -8.14% -8.23% -4.11% -6.18% -4.70% -12.88% -16.16% -18.97% -17.08% 140.04% -21.12% -26.80% -30.32% -7.29% -17.84% -29.04% -24.99% -15.26% -6.52% -9.86% -4.93% -12.11% 1.85% -20.07% -4.64% -16.24% -14.05% -23.36% -18.70% -16.40% -19.50% -26.21% -29.64% -19.50% -14.79% -17.21% -16.25% -3.01% -10.76% -31.90% -22.11% -12.98% -8.02% -9.26% -10.08% -15.67% -7.23% -8.56% -10.11% -7.82% -4.60% -6.87% -1.45% -5.74% -3.05%                     
  other income:                                                                                 
  interest expense-1,490,000 -1,416,000 -1,451,000 -1,667,000 -1,612,000 -1,677,000 -1,798,000 -1,772,000 -1,719,000 -1,636,000 -1,561,000 -1,324,000 -1,101,000 -1,000,000 -1,083,000 -1,449,000 -1,197,000 -1,189,000 -1,194,000 -1,232,000 -1,231,000 -1,228,000 -1,257,000 -1,113,000 -879,000 -862,000 -1,320,000 -1,246,000 -1,221,000 -820,000 -570,000 -576,000 -564,000 -554,000 -535,000 -530,000 -477,000 -259,000 -241,000 -16,000 -17,000 -18,000 -15,000 -24,000 -29,000 -237,000 -138,000 -123,000 -132,000 -173,000 -186,000 -190,000 -201,000 -224,259 -163,394 -170,223 -172,292 -308,514 -183,714 -199,978 -214,867 -263,013 -231,705 -241,480 -278,415 -60,727 -107,606 -173,952 -43,125 -39,388 -70,694 -49,466 -45,509 -47,436 -49,336 -51,218 -53,084 -54,922    
  interest income941,000 1,042,000 1,204,000 1,281,000 997,000 952,000 1,041,000 915,000 961,000 875,000 1,432,000 370,000 76,000 116,000 112,000 117,000 103,000 134,000 187,000 246,000 263,000 405,000 465,000 577,000 636,000 720,000 656,000 151,000 123,000 76,000 67,000 58,000 48,000 54,000 61,000 67,000 60,000 39,000 48,000 56,000 43,000 43,000 32,000 27,000 23,000 14,000 8,000 2,000 2,000 4,000 3,000 3,000 2,000 1,730 2,503 4,775 4,402 4,250 4,062 5,222 6,281 6,654 7,016 8,237 15,593 20,242 68,478 80,036 72,642 161,129 243,337 285,965 221,228 197,359 240,344 287,067 325,631 334,675    
  loss on debt extinguishment     -1,362,000                                                                            
  other income812,000 -180,000 51,500 260,000 28,000 -82,000                                                                     18,158  72,632   84,868  
  income before income tax expense-5,929,000 -6,508,000 -15,302,000 -7,531,000 -7,755,000 -13,086,000 -9,416,000 -9,008,000 -5,025,000 -6,398,000 -4,049,000 -12,226,000 -14,796,000 -15,127,000 -13,688,000 97,146,000 -16,185,000 -16,886,000 -18,464,000 -4,953,000 -8,224,000 -16,400,000 -16,048,000 -9,287,000 -4,091,000 -5,569,000 -3,351,000 -7,184,000 -290,000 -10,086,000 -2,632,000 -7,220,000 -6,866,000 -10,160,000 -8,609,000 -6,781,000 -8,189,000 -9,719,000 -10,898,000 -6,135,000 -4,883,000 -5,260,000 -5,347,000 -462,000 -2,687,000 -7,682,000 -4,976,000 -2,744,000 -1,786,000 -1,938,000 -1,990,000 -2,556,000 -1,320,000 -1,617,221            -7,996,162                
  income tax expense261,000 239,000 266,000 322,000 253,000 183,000 373,000 47,000 93,000 78,000 121,000 46,000 45,000 56,000   66,000 31,000   12,000 8,000 48,000 75,000 10,000 66,000 79,000 51,000 48,000 48,000 -52,000 26,000 17,000 23,000 16,000 2,000 17,000 5,000 -56,000 6,000 8,000 6,000 -69,000 4,000 5,000 27,000 4,000 4,000 5,000 5,000 30,000 11,000 6,000 2,559                         -4,707 -9,375  
  net income-6,190,000 -6,747,000 -15,568,000 -7,853,000 -8,008,000 -13,269,000 -9,789,000 -9,055,000 -5,118,000 -6,476,000 -4,170,000 -12,272,000 -14,841,000 -15,183,000 -13,741,000 97,108,000 -16,251,000 -16,917,000 -18,562,000 -4,949,000 -8,236,000 -16,408,000 -16,096,000 -9,362,000 -4,101,000 -5,635,000 -3,430,000 -7,235,000 -338,000 -10,134,000 -2,580,000 -7,246,000 -6,883,000 -10,183,000 -8,625,000 -6,783,000 -8,206,000 -9,724,000 -10,914,000 -6,141,000 -4,891,000 -5,266,000 -5,344,000 -466,000 -2,692,000 -7,709,000 -4,980,000 -2,748,000 -1,791,000 -1,943,000 -2,020,000 -2,567,000 -1,326,000 -1,619,780 -2,079,468 -1,156,336 -946,650 -1,273,046 11,544 -1,029,310 -764,506 -2,009,351 -2,390,028 -4,696,970 -1,443,068 -7,964,922 -1,742,006.25 -1,769,978 -1,592,616 -3,605,435 -1,565,381 -2,598,176 -2,787,090 -4,302,421 -4,263,565 -3,155,598      
  yoy-22.70% -49.15% 59.04% -13.27% 56.47% 104.89% 134.75% -26.21% -65.51% -57.35% -69.65% -112.64% -8.68% -10.25% -25.97% -2062.17% 97.32% 3.10% 15.32% -47.14% 100.83% 191.18% 369.27% 29.40% 1113.31% -44.40% 32.95% -0.15% -95.09% -0.48% -70.09% 6.83% -16.12% 4.72% -20.97% 10.45% 67.78% 84.66% 104.23% 1217.81% 81.69% -31.69% 7.31% -83.04% 50.31% 296.76% 146.53% 7.05% 35.07% 19.95% -2.86% 121.99% 40.07% 27.24% -18113.41% 12.34% 23.83% -36.64% -100.48% -78.09% -47.02% -74.77% 37.20% 165.37% -9.39% 120.91% 11.28% -31.88% -42.86% -16.20% -63.28% -17.66%          
  qoq-8.26% -56.66% 98.24% -1.94% -39.65% 35.55% 8.11% 76.92% -20.97% 55.30% -66.02% -17.31% -2.25% 10.49% -114.15% -697.55% -3.94% -8.86% 275.07% -39.91% -49.80% 1.94% 71.93% 128.29% -27.22% 64.29% -52.59% 2040.53% -96.66% 292.79% -64.39% 5.27% -32.41% 18.06% 27.16% -17.34% -15.61% -10.90% 77.72% 25.56% -7.12% -1.46% 1046.78% -82.69% -65.08% 54.80% 81.22% 53.43% -7.82% -3.81% -21.31% 93.59% -18.14% -22.11% 79.83% 22.15% -25.64% -11127.77% -101.12% 34.64% -61.95% -15.93% -49.12% 225.49% -81.88% 357.23% -1.58% 11.14% -55.83% 130.32% -39.75% -6.78% -35.22% 0.91% 35.11%       
  net income margin %-4.55% -5.46% -12.53% -6.78% -6.89% -12.19% -9.19% -9.21% -5.07% -6.93% -4.74% -14.74% -17.56% -20.36% -18.77% 137.82% -22.77% -28.54% -32.16% -9.04% -20.17% -30.83% -26.25% -16.54% -6.96% -10.44% -6.48% -14.49% -0.65% -21.56% -5.60% -17.19% -15.22% -24.67% -20.96% -17.69% -20.68% -27.06% -30.43% -19.54% -15.01% -17.62% -18.17% -1.75% -10.15% -31.03% -22.76% -13.64% -8.77% -10.00% -11.00% -15.91% -7.26% -9.27% -12.40% -7.60% -5.64% -8.14% 0.07% -7.11% -5.39%                     
  basic and diluted net income per share-0.13 -0.14 -0.33 -0.17 -0.17 -0.28 -0.113 -0.2 -0.11 -0.14   -0.32 -0.33   -0.36 -0.38 -0.43 -0.11 -0.2 -0.42 -0.43 -0.25 -0.11 -0.15 -0.09 -0.22 -0.01 -0.31 -0.08 -0.22 -0.21 -0.32 -0.27 -0.21 -0.26 -0.31 -0.37 -0.22 -0.18 -0.19 -0.19 -0.02 -0.1 -0.31 -0.24 -0.13 -0.09 -0.1 -0.13 -0.16 -0.08 -0.1 -0.13 -0.07 -0.06 -0.08  -0.07 -0.05 -0.13 -0.15 -0.32 -0.1 -0.56                
  weighted-average shares outstanding—basic and diluted47,721 47,393  47,105 46,909 46,719  46,411 46,266 46,107   45,692 45,528   45,035 44,632  44,012 41,649 38,671  37,842 37,334 36,976  33,601 33,252 32,926  32,576 32,288 32,020  31,706 31,575 31,358  27,462 27,304 27,069 26,374 26,915 26,849 24,766 20,431 20,725 20,652 19,544 16,190 16,278 16,132 16,015,877 15,671,993 15,810,978 15,613,410 15,396,307 15,095,250 15,148,815 15,025,522 14,997,009 14,563,710 14,614,217 14,456,542 14,296,612 14,191,000 14,208,232 14,184,973 14,149,963            
  comprehensive income:                                                                                 
  unrealized gain on investments   15 246 539 729 701 427 1,041     -764 -14 -132  -72 -85 174 -63 21 33 17 66 -32  8.75 -19                                              
  foreign currency translation adjustment979 805 -888 407 -118 -243 462 -276 36 -17 531 -260 -430 -178 29 -112 63 -299 327 238 101 -150 197 -255 115 -153 -31 -46 -211 86 43 29 342 73 -2 60 -219 286 -80 36 253 -487 255 -390 -28 -165 88 12 -144                                
  other comprehensive income979 805 -888 422 128 296 1,191 425 463 1,024     -735 -126 -69  255 153 275    132 -87 -63 -38 -210 78 44 37 346 75 -19 41 -206 327 -35.5 53 255  240 -410 -39  -176 93 11 -144                                
  comprehensive loss, net of tax-5,211 -5,942 -16,456 -7,431 -7,880 -12,973 -4,684.25 -8,630 -4,655 -5,452   -15,720 -17,700   -16,320 -17,247 -18,307 -4,796 -7,961 -16,621 -15,878 -9,584 -3,969 -5,722 -3,493 -7,273 -548 -10,056 -2,536 -7,209 -6,537                                                 
  other      9,000 -62,000 -123,000 145,000 216,000 -549,000 -111,000 -93,000 -215,000 -191,000 -14,000 54,000 46,000 24,000 29,000 -123,000 70,000 -114,000 -9,000 -107,000 -80,000 -41,000 -150,000 88,000 6,000 145,000 5,000 -18,000 -440,000 -32,000 -34,000 -80,000 -75,000 -48,000 -90,000 -141,000 -585,000 338,000 172,000 466,000 -8,000 -9,000 -17,000 31,000 45,000 160,000 199,000 101,294 -219,142 212,031 1,614 109,914 448,249 -2,221 -122,951 -64,496 -63,985 -35,129 -157,841 -23,557 241,066 142,071 203,289 169,139            
  operating expenses                                                                                 
  change in fair value of contingent consideration               -189,900,000                                                                  
  intangible asset impairment               82,300,000                                                                  
  net income per share                                                                                 
  basic net income per share          -0.09 -0.27   -0.31 2.15                                                                  
  diluted net income per share          -0.09 -0.27   -0.3 2.11                                                                  
  weighted-average shares outstanding                                                                                 
  basic      46,309    45,740 45,823   45,066 45,258                                                                  
  diluted      46,309    45,740 45,823   46,039 46,100                                                                  
  unrealized loss on investments          668 -691 -449 -2,339    -31                                                                
  other comprehensive loss          -1,086.75 -951 -879 -2,517    -330    -213 -44.25 -222                  -450                                        
  comprehensive income, net of tax          -2,971 -13,223   -14,476 96,982                                                                  
  comprehensive loss:                                                                                 
  operating (benefit) expenses:                                                                                 
  total operating (benefit) expenses              20,784,250 -46,443,000                                                                  
  income tax benefit              33,750 38,000   4,000 -4,000                                   56,962 -12,368 9,205 -4,501 18,813 -1,444 109 -1,790 -104,353 3,441 11,033 -31,240                
  comprehensive loss, net of tax:                                                                                 
  comprehensive loss                                 -10,108 -8,644 -6,742 -8,412 -9,397 -11,035 -6,088 -4,636 -5,716 -5,104 -876 -2,731 -7,709 -5,156 -2,655 -1,780 -2,087 -1,951 -2,470 -1,433 -1,566,324                            
  unrealized gains on investments                                    13 41 -41 17 37 -8.25 -20   -11                                  
  unrealized losses on investments                                            -11 -2   -1                                 
  income before income tax benefit                                                      -2,074,654 -1,143,968 -937,445 -1,268,545 30,831 -1,027,866 -764,397 -2,011,141 -2,402,953 -4,700,411 -1,454,101                 
  settlement reserve                                                              188,782 3,766,623                  
  goodwill impairment                                                                 6,812,389                
  revenues                                                             13,951,800 13,800,369 13,281,336 13,777,950 13,673,903 12,066,363 14,802,001 14,858,514 13,530,145 13,151,615 12,054,459 12,352,219 10,750,770 10,599,352 9,358,045 9,649,038 8,636,808 8,559,060 7,169,748 7,730,420 
  cost of revenues                                                             3,272,636 3,420,181 3,278,090 3,107,816 2,944,658 3,102,678 3,396,038 3,494,908 3,230,880 2,618,710 2,760,418 2,547,152 2,210,495 2,355,258 1,885,946 1,785,417 1,599,741 2,143,581 2,015,458 1,978,129 
  basic and diluted loss per share                                                                  -0.23 -0.12 -0.11 -0.25 -0.1 -0.18 -0.22 -0.35 -0.35 -0.26 -0.26 -0.26 0.08 -0.49 -1.24 
  grant income                                                                      121,630.75 74,190 74,190 338,143        
  foreign currency transaction gain                                                                      51,098.25 -65 122,754 81,703        
  weighted-average shares outstanding-                                                                                 
  basic and diluted                                                                      13,381,715 14,125,230 12,943,884  12,137,258 12,148,565  12,096,200 6,025,300 8,151,220 1,888,079 
  weighted-average shares outstanding- basic and diluted                                                                         12,298,424        
  preferred stock interest expense                                                                               -379,669 976,293 
  weighted-average shares outstanding:                                                                                 
  basic and diluted                                                                      13,381,715 14,125,230 12,943,884  12,137,258 12,148,565  12,096,200 6,025,300 8,151,220 1,888,079 
  (a) includes the following expenses resulting from transactions with enable medical corporation prior to the acquisition as of august 10, 2005:                                                                                 
  net income available to common shareholders                                                                            -3,208,341 -3,089,771 -4,009,512 -3,964,436 -2,342,838 
  weighted-average shares outstanding: basic and diluted                                                                            12,118,032     
  __________ (a) includes the following expenses resulting from transactions with enable medical corporation prior to the acquisition as of august 10, 2005:                                                                                 
  income before income taxes                                                                             -3,089,771 -4,004,805 -3,955,061  
  ____________ (a) includes the following expenses resulting from transactions with enable medical corporation prior to the acquisition as of august 10, 2005:                                                                                 
  other interest income                                                                              30,638 106,943 -5,192 
  expenses:                                                                                 
  total expenses                                                                                7,113,644 
  pro forma basic and diluted loss per share                                                                                -0.3 
  pro forma weighted-average shares outstanding:                                                                                 
  basic and diluted                                                                                7,900,099 
  (a) includes the following expenses resulting from transactions with related parties:                                                                                 
  (b) pro forma weighted-average shares has been adjusted to give effect to the conversion of all the outstanding shares of redeemable preferred stock into shares of common stock, which occurred august 2005.                                                                                 

We provide you with 20 years income statements for AtriCure stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AtriCure stock. Explore the full financial landscape of AtriCure stock with our expertly curated income statements.

The information provided in this report about AtriCure stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.